Anatomy and histology of the ovary
Anatomy: Relations, blood supply
Histology: Tunica albug, Germinal epithelium, Cortex, Medulla, follicle
Causes of male and female infertility
Male (30 %):
Female
Other causes (10 %) and unknown (10 %)
Folliculogenesis
Location, process (including related hormones), possible outcomes
Location: Folliculogenesis occurs in the cortex of the ovary
Process: The primordial follicle goes through a series of steps to achieve maturation. Approximately 5-6 follicles begin the folliculogenesis each cycle. The length of the follicular phase may vary whilst the luteal phase remains a constant 14 day period.
Primary follicle → secondary follicle → antral follicle (may progress to tertiary follicle) → Graafian follicle (mature ovum)
Antrum: A fluid filled cavity in the follicle. Contains secretions from granulosa cells
The most dominant follicle (may be due to high FSH receptor expression) is selected. The follicle becomes dominant and undergoes ovulation, which sees the perforation of the ovarian membrane and release of the oocyte into the abdominal cavity. The oocyte is captured by infundibular associated fimbrae.
The follicle becomes the progesterone secreting corpus luteum.
Associated hormones:
FSH window is seen: This is where FSH levels peak. Follicles experience a ‘surge’ in growth. It is at this point that the follicle which displays dominance is selected - this is as the peak in FSH level persists for only a short period.
Possible outcomes:
Following ovulation the oocyte may be fertilised → zygote.
The corpus luteum maintains the endometrial linign through secretion of progesterone.
Once the placenta is established, 12-13 weeks, the corpus luteum becomes the corpus albicans.
Gametogenesis
x

HPO disorders
Possible causes
Stress, weight change (e.g. eating disorder), excessive exercise, PCOS, congenital adrenal hyperplasia, primary hypothyroidism
⋆ Can lead to luteal phase deficiency and infertility
Hypogonadotropic hypogonadism
Normogonadotropic normogonadism
Hypergonadotropic hypogonadism

Ovarian Physiology
Ovarian cycle: Follicular and luteal phases
Physiology of conception
Ovum generation, intercourse, capacitation and fertilisation
Intercourse
Capacitation of sperm
Fertilisation
Expanded cumulus, zona pellucida and plasma membrane of the egg (oolemma)
Puberty
Age of onset, secondary sexual characteristics, stages endocrine control
Age of onset: 8 - 13 females, 9 - 14 males
Secondary sexual characteristics:
Stages:
Female: Thelarche, pubarche, growth spurt menses
Males:
Endocrine control
Anovulation and relationship to obesity
Obese females are at increased risk of anovulation and infertility
Causes and features of amenorrhoea
Causes: Pregnancy, PCOS, infertility, hyperprolactaemia, eating disorders, stress, post-contraception withdrawal (progesterone), hypothyroidism, congenital adrenal hyperplasia, ovarian failure, chemo/radio-therapy
Features: Absence of menses for > than 6 months or for 3 menstrual cycles

Control of fertility and infertility in males and females
Causes of infertility in females: Tubal (25 %) - adhesions, occlusions; ovulatory (25 %)
Causes of infertility in males: Pre-testicular, testicular and post-testicular
Hormone analysis
Tests for fertility, tubal patency and semen analysis
Fertility testing:
Includes FBC, chlamydia testing, ultrasound,
Tubal patency:
Semen analysis: Seminogram
Oligozoospermia: Low sperm count
Asthenozoospermia: Movement abnormalities
Teratospermia: Abnormal morphology
Azoospermia: No sperm in ejaculate
Polycystic ovary syndrome
Definition, features, diagnosis and long term consequences
Definition: A syndrome characterised by androgen excess and ovarian dysfunction
Features: Hirsutism, amenorrhoea, acne, weight gain, infertility, elevated blood pressure
Diagnosis: Rotterdam Criteria (at least 2 present)
Long term consequences: T2DM, NAFLD, CVD, endometrial cancer
Ethical considerations: Termination of pregnancy and IVF
IVF:‘Excess’ embryos may be used for research; IVF increases the likelihood of multiple pregnancies (danger for mother); costs large amounts of money that may be spent elsewhere; places ‘strain’ upon the couple if it is unsuccessful
Termination of pregnancy: Allows maternal choice; is effectively ending a life;
Public health implications of STDs
x
Endocrinological basis on contraception
Targets the HPO axis, preventing the maturation of follicles and subsequent ovulation.
Oestrogen: Inhibits the secretion of FSH, through negative feedback on the HPO axis, preventing maturation of the follicle
Progesterone: Inhibits secretion of LH, preventing ovulation
Contraception inhibits ovulation via hormonal control.
Also acts to induce chances in the uterine environment, decreasing the likelihood of pregnancy. Decreases uterine tube peristalsis, endometrial proliferation and also causes the endometrium to be less receptive to implantation.
Menopause
Loss of fertility and ovarian function.
Average age: 51 y/o
Classified as menopause following 1 year after the LMP
Physiology: Oestrogen levels decrease, as follicle maturation ceases. Decreased oestrogen levels means negative feedback on the HPO axis is removed, leading to increased levels of FSH and LH.
Symptoms: Hot flashes, vaginal dryness, night sweats, acne, thinning hair, dry skin
STRAW +10 classification used: Reproductive, menopausal transition and post-menopausal stages
Causes of pelvic pain
PID: A combined infection of the fallopian tubes, ovaries and peritoneum
Salpingitis: Inflammation of the uterine tube
Endometriosis: Ectopic growth of endometrial tissue outside of the uterine cavity with cyclic bleeding abilty, leads to inflammation.
Adenomyosis: Growth of the endometrial tissue within the uterine myometrium.
Ectopic pregnancy:
Malignancy:
Iatrogenic e.g post-surgical adehesions
Ovarian and menstrual cycles: Stages
*Draw hormone level diagram*
Ovarian cycle:
Follicular: Associated with the growth and maturation of the follicle (contained in the cortex). Mediated by FSH. The follicle secretes oestrogen.
Luteal: Follows the ovulation, mediated by LH, of the follicle and release of the oocyte. The corpus luteum (remnant of the follicle) secretes progesterone, promoting the maintenance of the endometrial lining. Oestrogen levels also remain relatively high, allowing for further endometrial proliferation.
Menstrual cycle:
Proliferative: Oestrogen promotes the growth of endometrial stratum functionalis and the spiral arteries.
Secretory: Progesterone promotes endometrial secretion. The endometrium becomes more cork-screw like and the spiral arteries become more ‘coiled’. Mid-luteal a change from endothelial stroma to secretory decidual cells is seen - secrete glycogen and lipid droplets which provide nutrition for the embryo.
Outline the HPO axis

Causes of abnormal uterine bleeding (AUB)
Stuctural
Polyps
Adenomyosis
Leiomyoma (fibroids)
Malignancy
Functional
Coagulopathy
Ovulatory
Idiopathic
Not yet classified
Mechanism of action of steroid hormones
Early pregnancy and implantation (7.3)
Early pregnancy:
Fertlisation → Cell cleavage→Generation of 16 cell morula (day 3)→ Blastocyst forms (day 5) (out trophoblast and inner cell mass) → Shedding of the zona pellucdia (day 6) and adimplantation →bilaminar disk formation (inner cell mass → epiblast and hypoblast) → outer trophoblast layer gives rise to the cytotrophoblast and syncytiotrophoblast cells
Implantation:
Day 8 - Invasive syncytiotrophoblast cells secrete lytic enzymes and apoptosis inducing factors which allow for the invasion of the endometrium.
The syncytiotrophoblasts invade nearby blood vessels and glands. Blood filled lacunae form in the trophoblast layer. Can cause implantation spotting.
Day 13 - The blastocyst becomes embedded in the uterine endometrium and the uterine epithelium ‘seals’ the site of invasion.
The syncytiotrophoblast secretes hCG to maintain the progesterone secreting corpus luteum. Progesterone allows for maintenance of the endometrium. Once established the placenta will assume this role.